saroglitazar
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Background The potential for PPAR agonists to positively affect risk of cardiovascular disease in patients with type 2 diabetes…
Background Diabetes and other metabolic abnormalities including high triglycerides (TGs) are commonly seen comorbid conditions in…
Oxidative stress and neuroinflammatory process are implicated in pathophysiology of epilepsy as well as epileptogenesis. The a…
The thiazolidinedione class PPARγ agonists as antidiabetic agents are restricted in clinical use because of the side effects such…
Saroglitazar is a novel nonthiazolidinediones (TZD) and nonfibric acid derivative designed to act as dual regulator of lipids and…
Diabetes mellitus (DM) is one of the most dreaded metabolic disorders in the world today. It is the leading cause of morbidity…
Cardiovascular risk reduction is an important issue in the management of patients with Type 2 diabetes mellitus. Peroxisome…
Background: Dual PPARα/γ can improve both metabolic effects and minimized the side effects caused by either PPARα or PPAR…
BACKGROUND
Dyslipidemia due to diabetes is characterized by hypertriglyceridemia and reduced levels of high-density lipoprotein…
Diabetes mellitus is a worldwide prevalent chronic disease with a significant disease burden. The associated dyslipidemia adds to…